#Animal Antimicrobial And Antibiotics Market Research Analysis

[insightfulblogz]

Bovine Mastitis Market : In-depth Analysis by Trends, Dynamics, Drivers, Challenges and Growth Factors by 2032

Bovine mastitis is a prevalent and economically significant inflammatory condition of the mammary gland in dairy cows, primarily caused by bacterial infections. It leads to decreased milk production, reduced milk quality, and increased veterinary costs, posing substantial challenges for dairy farmers globally. The condition can be classified into clinical and subclinical forms, with the latter being more difficult to detect but equally detrimental to herd health and profitability. Effective management of bovine mastitis requires a comprehensive approach, including prompt diagnosis, appropriate treatment, and preventive measures to minimize the risk of recurrence. As the dairy industry continues to evolve, addressing the challenges posed by mastitis has become a priority for farmers, veterinarians, and researchers alike.

The Bovine Mastitis Market size was USD 0.60 Billion in 2023 and is expected to Reach USD 0.98 Billion by 2031 and grow at a CAGR of 6.4% over the forecast period of 2024-2031.

Future Scope

The future of bovine mastitis management is increasingly focused on integrating technology and data-driven approaches to enhance detection and treatment. The adoption of on-farm diagnostic tools, such as portable milk analysis devices and somatic cell count monitoring systems, is expected to improve early detection of mastitis. Additionally, advancements in genomics and biotechnology may lead to the development of mastitis-resistant cattle through selective breeding. Furthermore, the use of precision livestock farming techniques will allow farmers to monitor individual cow health and well-being more effectively, facilitating timely interventions and reducing the incidence of mastitis.

Trends

Recent trends in the management of bovine mastitis emphasize a holistic and proactive approach to dairy herd health. There is a growing emphasis on preventive strategies, including proper milking techniques, hygiene practices, and housing conditions to reduce the risk of infection. The use of antimicrobial alternatives, such as probiotics and immunomodulators, is also gaining traction as a means to reduce reliance on antibiotics and mitigate the risk of antimicrobial resistance. Education and training programs for dairy farmers and workers are being prioritized to promote best practices in mastitis management, ultimately leading to improved herd health and productivity.

Applications

Effective management of bovine mastitis involves a range of applications aimed at diagnosis, treatment, and prevention. Diagnostic methods include milk culture, somatic cell count testing, and clinical examination to identify infected animals accurately. Treatment typically involves antibiotic therapy, although the choice of treatment should be guided by culture results to ensure efficacy and reduce antibiotic resistance. Preventive measures, such as implementing strict biosecurity protocols, regular health checks, and proper milking hygiene, are essential to minimize the risk of mastitis within the herd. Additionally, ongoing research into vaccine development aims to provide an effective means of preventing mastitis caused by specific pathogens.

Key Points

Bovine mastitis is a significant inflammatory condition affecting dairy cows, impacting milk production and quality.

Effective management requires prompt diagnosis, treatment, and preventive measures.

The future of mastitis management includes technological advancements and data-driven approaches.

Preventive strategies and education are becoming increasingly important in dairy herd health.

Research into alternative therapies and vaccines is ongoing to combat bovine mastitis.

Conclusion

Bovine mastitis remains a critical challenge within the dairy industry, affecting animal health, farm profitability, and milk quality. However, advancements in technology, a focus on preventive strategies, and a commitment to education and best practices are paving the way for more effective management of this condition. By prioritizing bovine mastitis control and prevention, the dairy sector can enhance animal welfare, improve productivity, and ensure the sustainability of dairy farming for future generations.

Read More Details: https://www.snsinsider.com/reports/bovine-mastitis-market-3240 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[insightreportsunivdatos]

Antibiotic Resistance Market Size, Share, Growth, Trends and Forecast 2024-2032

Antimicrobials relate to antibiotics, antivirals, antifungals, and antiparasities which are classifications of drugs administered in controlling diseases caused by microorganisms in humans, animals, and plants. Antimicrobial Resistance (AMR) defines any activity of bacteria, viruses, fungi, and parasites to known antimicrobial medicines. Drug resistance means that even antibiotics and other antimicrobial treatments are rendered ineffective and infections can become hard or even impossible to handle, leading to increased danger of disease transmission, severe disease, disability, and death. As a naturally occurring process, AMR occurs through gradual pathogen evolution over a period through mutations. It has been promoted and spread by human endeavors especially the irrational and excessive use of antimicrobials for prevention, treatment, or control of infections in man, animals, and crops.

According to the Univdatos Market Insights analysis, increasing cases of antibiotic-resistant infections and increasing investment in antibiotic research & development activities across the globe will drive the scenario of the antibiotic resistance market. As per their “Antibiotic Resistance Market” report, the global market was valued at ~USD 8.3 billion in 2023, growing at a CAGR of about 5.4% during the forecast period from 2024-2032.

Request Free Sample Pages with Graphs and Figures Here - https://univdatos.com/get-a-free-sample-form-php/?product_id=66996

A GLOBAL CONCERN:

Antimicrobial medicines are the cornerstone of modern medicine. The emergence and spread of drug-resistant pathogens threaten our ability to treat common infections and to perform life-saving procedures including cancer chemotherapy and cesarean section, hip replacements, organ transplantation, and other surgeries. In addition, drug-resistant infections impact the health of animals and plants, reduce productivity in farms, and threaten food security. AMR has significant costs for both health systems and national economies overall. AMR is a concern for every country irrespective of income level. It does not respect the territorial standards or boundaries of countries. They include adequate availability and utilization of clean water, sanitation, and hygiene (WASH) for humans and animals; inadequate prevention, infection, and disease control in human and animal households, health care, and farming sectors; Inadequate access to proper, affordable, and effective vaccines, diagnostic tools, and medicines; poor knowledge or health literacy; and all implementing regulations. Both the driving force as well as the effect of AMR bear more influence on individuals dwelling in developing nations and at-risk communities.

Ø Drug resistance in bacteria-

The worldwide spread of antibiotic resistance remains a major concern while the effectiveness of widespread bacterial infections is reduced due to the ineffectiveness of most used antibiotics. According to the 2022 Global Antimicrobial Resistance and Use Surveillance System (GLASS) report, some of the bacteria pathogens have high resistance rates and this is a big worry. The crude resistance rate of third-generation cephalosporin-resistant Escherichia coli is 42 % and methicillin-resistant Staphylococcus aureus is 35% in 76 countries which is reportedly high. Klebsiella pneumoniae, which is a bacterial isolate from human intestines, has also raised its resistance to several important antibiotics. Higher levels of resistance may translate to greater adoption of the last resort drugs such as carbapenems which in turn have their resistance levels which are presently being noted across the world. As the effectiveness of the last-resort drugs diminishes, the danger of infections that can no longer be treated rises. According to the Organization for Economic Cooperation and Development projections, there is a predicted twofold increase in resistance to last-line antibiotics by 2035 as compared to the year 2005 implying the need to invest in effective antimicrobial stewardship and improve surveillance across the world.

KEY FACTS:

Ø AMR has been reported to threaten many advancements in modern medicine. They also prove more difficult to eliminate and increase complications attached to other medical operations and therapies including surgery, cesarean section, and cancer chemotherapy.

Ø The world faces an antibiotics pipeline and access crisis. There is an inadequate research and development pipeline in the face of rising levels of resistance, and an urgent need for additional measures to ensure equitable access to new and existing vaccines, diagnostics, and medicines.

Ø In addition to death and disability, AMR has significant economic costs. The World Bank estimates that AMR could result in USD 1 trillion in additional healthcare costs by 2050, and USD 1 trillion to USD 3.4 trillion in gross domestic product (GDP) losses per year by 2030.

For more information about this report visit- https://univdatos.com/report/antibiotic-resistance-market/

Conclusion

The gradual development of the extensive and imaginative healthcare research business is showing a new day. All these measures are changing the manner of managing the industry at the moment offering numerous varieties to the population on the international level. 

[pharmacoviligiance]

Veterinary Pharmacovigilance: Ensuring Animal Health and Safety

Introduction

Pharmacovigilance, a branch of pharmacology, is traditionally associated with monitoring drug effects and safety in humans. However, the discipline also plays a crucial role in veterinary medicine. Veterinary pharmacovigilance involves the science of detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems in animals. As the veterinary pharmaceutical market expands and evolves, a robust pharmacovigilance system is essential in protecting animal health and ensuring public safety.

The Need for Veterinary Pharmacovigilance

The safety and efficacy of veterinary drugs are paramount, especially as they directly impact animal health, food safety, and public health. Adverse drug reactions in animals can lead not only to medical complications for the animals themselves but also to wider repercussions, including compromised food safety for consumers and the potential for drug residues to enter the human food chain.

In recent years, there has been a growing concern about antimicrobial resistance, which can arise from the improper use of veterinary drugs. Pharmacovigilance can help identify patterns of adverse drug reactions, monitor resistance trends, and promote safe drug usage, thus contributing to the overarching goal of responsible antibiotic stewardship.

Key Components of Veterinary Pharmacovigilance

Data Collection: Veterinary pharmacovigilance begins with the systematic collection of data on adverse drug reactions (ADRs) and other drug-related issues. Veterinary professionals, including veterinarians and pharmacologists, are encouraged to report any suspected ADRs. This data can be collected through various channels, including veterinary clinics, research institutions, and regional or national veterinary health organizations.

Data Analysis: Once the data is collected, it undergoes rigorous analysis to identify trends, risk factors, and potential causal relationships between drugs and adverse outcomes. Advanced statistical methods and software tools are often employed to ensure accuracy and reliability.

Risk Assessment: Risk assessment is a critical function of veterinary pharmacovigilance. It involves evaluating the likelihood of harm arising from the use of a drug based on the collected data. This assessment helps determine whether a risk is acceptable or if regulatory actions are warranted.

Regulatory Actions: Based on the findings from the risk assessment, regulatory agencies may take various actions. These can include updates to drug labeling, issuing warnings about potential side effects, or even recalling drugs from the market if they pose significant risks to animal or public health.

Communication and Education: Effective communication strategies are vital to ensuring that veterinary professionals and pet owners are aware of potential risks associated with veterinary drugs. Educational initiatives can help increase awareness about the importance of reporting adverse effects and promote responsible drug usage.

Challenges in Veterinary Pharmacovigilance

While essential, veterinary pharmacovigilance faces several challenges. One major hurdle is underreporting; many veterinary professionals and owners may not report ADRs due to a lack of awareness or fear of repercussions. In addition, the diversity of animal species and the unique contexts in which veterinary drugs are used complicate the data collection and analysis processes.

Another challenge is harmonizing international pharmacovigilance efforts. Differences in drug approval processes, regulatory frameworks, and reporting systems across countries can hinder global collaboration and data sharing.

The Future of Veterinary Pharmacovigilance

The future of veterinary pharmacovigilance is likely to grow in importance as developments in technology, science, and regulations continue to reshape the veterinary landscape. The integration of electronic health records, artificial intelligence, and big data analytics may offer new opportunities for real-time monitoring of drug safety and efficacy in veterinary medicine.

Furthermore, as the interconnections between animal health and human health become increasingly recognized—often referred to as the "One Health" approach—veterinary pharmacovigilance will need to expand its scope to consider the implications of veterinary drug use on public health and ecosystem stability.

Conclusion

Veterinary pharmacovigilance serves as a vital framework for ensuring the safe and effective use of veterinary drugs, protecting animal health, and safeguarding public welfare. As the veterinary pharmaceutical landscape evolves, ongoing efforts to enhance reporting, analysis, and regulation will be essential. By fostering a culture of safety and responsibility within the veterinary community, we can promote better health outcomes for animals and humans alike.

[shubhampawrainfinium]

"Breakthrough or Bust? A Critical Look at Animal Antibacterial Peptide Market Opportunities"

Introduction

Animal antibacterial peptides are emerging as a significant frontier in the fight against bacterial infections in veterinary medicine. These peptides, naturally occurring in animals, exhibit antimicrobial properties that make them valuable for treating a range of infections and enhancing animal health. With rising concerns about antibiotic resistance and the limitations of traditional antibiotics, animal antibacterial peptides offer promising alternatives. This report provides a detailed analysis of the animal antibacterial peptide market, including key drivers, challenges, and opportunities. It explores regional dynamics, market segmentation, and the competitive landscape to offer insights into current trends and future prospects in this evolving field.

Market Dynamics

Drivers:

Rising Antibiotic Resistance: Increasing resistance to conventional antibiotics in veterinary medicine is driving the demand for novel antimicrobial solutions like animal antibacterial peptides, which offer an alternative approach to combating infections.

Advancements in Peptide Research: Innovations in peptide synthesis and research are enhancing the efficacy and stability of animal antibacterial peptides, contributing to their growing adoption in veterinary applications.

Growing Focus on Animal Health: Enhanced awareness of animal health and welfare is leading to increased investments in advanced treatments and preventive measures, including the use of antibacterial peptides.

Challenges:

High Development Costs: The research, development, and production of animal antibacterial peptides involve significant costs, which can be a barrier to market entry and expansion.

Regulatory Hurdles: Navigating the complex regulatory landscape for veterinary products, including the approval of new peptide-based treatments, poses challenges for manufacturers.

Market Education and Acceptance: Educating veterinarians and pet owners about the benefits and effectiveness of antibacterial peptides compared to traditional treatments can be challenging, impacting market adoption.

Opportunities:

Emerging Markets: Expanding veterinary healthcare infrastructure in emerging markets offers opportunities for growth in the animal antibacterial peptide sector, as these regions increase their focus on advanced animal health solutions.

Innovative Applications: The development of new applications and formulations for animal antibacterial peptides, such as combination therapies or targeted treatments, presents opportunities for market expansion.

Strategic Partnerships: Collaborations between peptide researchers, veterinary pharmaceutical companies, and academic institutions can accelerate innovation and market penetration.

Sample Pages of  Report: https://www.infiniumglobalresearch.com/reports/sample-request/1008

Regional Analysis

North America: The North American market is advanced, with a strong focus on veterinary research and development. The U.S. and Canada are key players, driven by high investments in animal health and a growing interest in alternative treatments for antibiotic-resistant infections.

Europe: Europe shows robust growth due to a strong emphasis on animal welfare and regulatory support for innovative veterinary treatments. The region's advanced healthcare systems and research capabilities contribute to the market's expansion.

Asia-Pacific: The Asia-Pacific region is experiencing significant growth due to rising investments in veterinary care and increasing awareness of advanced treatment options. Countries like China and India are driving demand for novel antibacterial solutions, including peptides.

Latin America: The Latin American market is growing steadily as veterinary care improves and awareness of advanced treatments increases. Economic factors and regulatory challenges may impact market growth, but there is potential for expansion.

Middle East and Africa: The market in this region is relatively nascent but developing, with increasing investments in veterinary healthcare and rising demand for advanced animal health solutions contributing to market growth.

Market Segmentation

By Type:

Cationic Peptides

Non-Cationic Peptides

Hybrid Peptides

Others (e.g., cyclic peptides)

By Application:

Companion Animals (e.g., dogs, cats)

Livestock (e.g., cattle, poultry, swine)

Aquaculture

Others (e.g., exotic animals)

By Distribution Channel:

Veterinary Clinics

Animal Health Pharmacies

Online Platforms

Distributors

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

Competitive Landscape

Market Share and Pricing:

Large players such as Eligo Bioscience and Nanosphere Health hold significant market share due to their advanced research capabilities and established market presence. These companies have considerable influence over pricing due to their scale and technological advantages.

Price Control:

Major players often set market standards for pricing, driven by their ability to leverage extensive research and development resources. They also establish pricing structures based on product efficacy and market demand.

Competition from Small and Mid-Size Companies:

Smaller and mid-sized companies challenge larger players by focusing on niche applications or developing innovative peptide formulations. These companies contribute to market diversity and drive innovation.

Key Players:

Eligo Bioscience

Nanosphere Health

Sederma

PeptiDream Inc.

Ablynx (now part of Sanofi)

Report Overview: https://www.infiniumglobalresearch.com/reports/global-animal-antibacterial-peptide-market

Future Outlook

New Product Development: New product development is crucial for advancing the animal antibacterial peptide market. Innovations in peptide design and formulation can enhance effectiveness and open new application areas, driving growth and addressing emerging needs in animal health.

Sustainable Products: Sustainable practices in peptide production and use are becoming increasingly important. Products that demonstrate environmental responsibility and ethical considerations are likely to gain strong customer support and regulatory favor.

Conclusion

The animal antibacterial peptide market is poised for growth, driven by the need for alternatives to traditional antibiotics and advancements in peptide research. While challenges such as high development costs and regulatory hurdles persist, opportunities in emerging markets and innovative applications offer promising prospects. Companies that focus on new product development and sustainability are likely to lead the market, meeting evolving demands and contributing to advancements in animal health.

[pharmanucleus1]

Anti-Coccidial Drugs Market : Unlocking Opportunities with Gorwth Insights and Advancements

Anticoccidial Drugs Market Insights 

In April 2019, Creative Diagnostics developed anticoccidial drug assay products to test anticoccidial drug residues in animals. This advancement and awareness of anticoccidial drugs will impact the trend of the anticoccidial drugs market. Growing awareness of animal health and zootonic diseases is expected to increase acceptance of anticoccidial drugs. The rising carnivorous population and reliance on bovine products is expected to be a driving factor for the growth of the anticoccidial drugs market. Additionally, the increase in research and development of veterinary drugs is expected to provide growth opportunities for anticoccidial drugs. 

Click here for full report:

The growth of the global anticoccidial drugs market is expected to be driven by increasing outbreaks of coccidia combined with growing reliance on poultry products. Additionally, stringent government regulations aimed at maintaining livestock health in developed countries are expected to increase the adoption of anticoccidial drugs. Growing expenditure and pet owners' awareness of animal health is expected to be a driving force for the anticoccidial drugs market. 

Conversely, certain government policies restricting the use of anticoccidial antimicrobial drugs in livestock are expected to inhibit the growth of the anticoccidial drugs market. Additionally, the growing demand for antibiotic-free meat has likely impacted the growing trend of the anticoccidial drugs market. 

Anticoccidial Drugs Market Segment Analysis 

By Drug Type 

Ionophore Anticoccidials 

Chemical Derivative Anticoccidials 

Click here fore free sample request:

By Animal Type 

Poultry 

Swine 

Cattle 

Others 

Competitive Key Players 

Bayer Animal Healthcare 

Boehringer Ingelheim 

Ceva Animal Health Inc. 

Elanco Animal Health (a subsidiary of Eli Lilly) 

Merck 

Merial 

Virbac 

Zoetis Animal Healthcare 

Vetoquinol SA 

Click here for full report:

Anticoccidial Drugs Market Geographical Analysis 

The global anticoccidial drugs market has been segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Developed countries in North America and Europe are estimated to dominate the global anticoccidiosis drug market due to established veterinary care and active government involvement in farm animal health and management. Asia-Pacific and Latin America countries are expected to register higher CAGR in the global anticoccal drugs market growth due to growing dependence on farm animals and an increasing number of pet owners of the company. In the Middle East and Africa, the unmet need for animal health is expected to be a driver of the anticoccal drugs market in the region. 

Anticoccidial Drugs Market Key Developments 

In 2014, Zoetis announced the reintroduction of Zoamix, a synthetic anticoccidial drug indicated for poultry. 

In February 2015, Zoetis announced the completion of its acquisition of Abbott's animal health business. 

In May 2016, Laboratorios Hipra received European Union approval for the company's coccidiosis vaccine Evalon

[market-insider]

Emerging Trends in Veterinary Antibiotics: Europe Market Analysis

The Europe veterinary antibiotics market size is expected to reach USD 1.31 billion by 2030. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

Gain deeper insights on the market and receive your free copy with TOC now @: Europe Veterinary Antibiotics Market Report

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

[marketing123456789]

Rapid Advancements in Animal Feed Additives Propel Market Growth by 2033

The animal feed additives market is expected to grow from US$ 16,067 million in 2023 to US$ 19,877.0 million by 2033, with a significant compound annual growth rate (CAGR) of 2.0% during the forecast period.

The increased production of livestock has raised concerns about public health issues related to the use of antibiotics and the spread of foodborne diseases. As a result, probiotics or direct-fed microbials are gaining popularity in the animal feed market, as they promote gut health, overall productivity, and well-being in animals.

Probiotics also help control enteric pathogens and improve digestion and immune systems in animals such as cattle, ruminants, and poultry. Yeast-based probiotics are commonly used in swine, poultry, and ruminants.

Find a comprehensive report summary that describes the market size and forecast along with the research methodology. The Sample report is available in PDF format@ https://www.futuremarketinsights.com/reports/sample/rep-gb-418

Commercial probiotic-based animal feed additives usually contain microorganisms such as lactobacillus, streptococcus, bacillus, Pedi coccus, and Bifidobacterium. The demand for probiotics is expected to increase as the market shifts toward antibiotic-free meat. Adequate labeling of animal feed products is important to ensure safety and enable buyers to make informed choices.

Government regulations require proper labeling of feed ingredients, including complete lists of ingredients and nutrient levels. Balanced animal diets are crucial for livestock growth, development, and reproduction.

Animals have varying dietary requirements, and the inclusion of proper animal feed additives is necessary to enhance nutritional content. Insufficient nutrients can lead to malnutrition and health issues in animals.

Farmers are increasingly incorporating sustainable methods and investing in research and development to produce high-quality animal feed additives that improve livestock yield and the quality of end products such as eggs and milk.

Key Takeaways:

The animal feed additives market in the United States held a significant value share of 29.3% in 2022. The market is driven by increasing livestock production in the United States and Mexico, and strict government regulations on meat quality and animal feed additives.

In China, the demand for animal feed additives is estimated to thrive with a CAGR of 2.1%, fueled by rising per capita expenditure on high-quality food products and increased disposable income.

Germany is expected to lead the animal feed additives market in Europe, with a CAGR of 3%, driven by the sales of ready-to-eat and packaged meat products and stringent food regulations.

India is a promising market with a transforming CAGR of 2.4%, driven by the increasing consumption of animal protein and rising disposable income.

Amino acids are the most preferred product type, accounting for a significant share of 33.1% in 2022, as they play a crucial role in muscle and tissue development, reproduction, and overall animal health.

Plant-based animal feed additives are gaining traction due to their medicinal, antimicrobial effects, and their ability to improve growth performance and enhance the flavor and odor of feed.

Discover the In-Depth Analysis@ https://www.futuremarketinsights.com/reports/animal-feed-additives-market

Competitive Landscape

The animal feed additives industry is highly concentrated, with large global and regional companies present. In the face of fierce rivalry, the top five competitors, which include BASF SE, EVONIK INDUSTRIES AG, Cargill, Inc., Koninklijke DSM N.V., and Nutreco N.V., are expected to account for 30-40% of the overall market share.

In March 2021 Ajinomoto Co. joined forces with Pegasus Tech Ventures, a worldwide venture capital firm, to invest in Silicon Valley-based start-ups to capitalize on growing trends in the food and healthcare sectors. The collaboration is going to allow the organization to expand its geographical footprint to 16 sites worldwide.

Key Companies Profiled

Neogen

Zoetis

Merck

Boehringer Ingelheim

Elanco

Dechra Pharmaceuticals

IDEXX Laboratories

B. Braun Vet Care

Medtronic

Animal Feed Additives Market by Category

By Additive Type:

Antibiotics

Vitamins

Antioxidants

Amino Acids

Feed Enzymes

Feed Additives

Minerals

By Application Type:

Ruminants

Poultry

Swine

Aquatic

By Source Type:

Plant

Animal

Micro-organisms

By Region:

North America

Latin America

Europe

South Asia & Pacific

East Asia

The Middle East & Africa (MEA)

About Future Market Insights, Inc. Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

[delvenservices]

Animal Antibiotics and Antimicrobials Market Portfolio

Animal Antibiotics and Antimicrobials Market Research Report Information by Delivery Type (Injections, Oral powder, Oral solutions, Premixes, Others), Product Type (Aminocoumarins, Aminoglycosides, Bicyclomycin, etc) and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The global Animal Antibiotics and Antimicrobials Market is growing with the CAGR of 6.85% in the forecast period of 2021 to 2028 and is expected to reach USD 10.37 billion by 2027.

The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food.

The factors such as the growing need for the animal-derived food products, the growing of the prevalence of the zoonotic diseases, the applications of the guidelines for stopping the spread of the animal diseases and the increasing need for the pet insurance and the rising of the animal health expenses are some of the factors that have supported long-term expansion for Animal Antibiotics and Antimicrobials Market.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/animal-antibiotics-and-antimicrobials-market-trends-forecast-till-2028

Regional Analysis

North America dominates the animal antibiotics and antimicrobials market because of the increasing number of companion animal healthcare spending, cumulative demand for animal-derived food products, and occurrence of various food-producing. Furthermore, increasing alertness about zoonotic diseases will further boost the growth of the animal antibiotics and antimicrobials market in the region.

Key Players

Zoetis

Boehringer Ingelheim International GmbH

Merck & Co., Inc.

Ceva, Eli Lilly and Company

Bayer AG

Dechra Pharmaceuticals PLC

Virbac, Vetoquinol S.A

Boehringer Ingelheim GmbH

Sanofi

Bioniche Animal Health

Elanco

Fort Dodge Animal Health

Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/animal-antibiotics-and-antimicrobials-market-trends-forecast-till-2028

Recent Developments

September 2020, Zoetis announced the launch of Vetscan Imagyst™, a diagnostic platform that uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence (AI) to deliver accurate testing results to the clinic.

June 29, 2021 - Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development and delivery of next-generation vaccines by bringing together approximately 400 dedicated employees integrating end-to-end mRNA vaccine capabilities with dedicated R&D, digital, and chemistry, manufacturing and controls (CMC) teams across sites at Cambridge, MA (US) and Marcy l’Etoile, Lyon (France).

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for Animal Antibiotics and Antimicrobials Market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Purchase the Research Report: https://www.delvens.com/checkout/animal-antibiotics-and-antimicrobials-market-trends-forecast-till-2028

Report Scope

Animal Antibiotics and Antimicrobials Market is segmented into delivery type, end user, product type and region.

On the basis of Delivery Type

Injections

Oral powder

Oral solutions

Premixes

On the basis of End-User Industry

Companion animals

Food producing animals

On the basis of Product Type  

Aminocoumarins

Aminoglycosides

Bicyclomycin

Cephalosporins

Fluoroquinolones

Fusidic acid

Macrolides

Penicillin

Phenicols

Sulfonamides

Tetracyclines

On the basis of Region

Asia Pacific

North America

Europe

South America

Middle East & Africa

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

 SALES@DELVENS.COM

[impossibledeanmakerwombat]

Aquaculture Vaccines Market Insights, Deep Analysis of Key Vendor in the Industry to 2033

According to a recently published industry analysis report by Future Market Insights, the Aquaculture Vaccines Market had worldwide sales of US$ 374.9 Million in 2022. The anticipated market growth between 2023 and 2033 is anticipated to be greater than historical growth, at 8.5%. The Injected Vaccines segment is anticipated to generate a sizable amount of revenue, with a CAGR of 8.6% from 2023 to 2033.

According to market research and competitive intelligence provider Future Market Insights’ analysis of the aquaculture vaccines market, from 2018 to 2022, the industry’s market value grew at a rate of about 8.1% CAGR, with the United States, the United Kingdom, China, Japan, and South Korea accounting for a sizeable portion of the global market.

Get Latest Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16501

Many diseases in domestic animals and terrestrial cattle are prevented by vaccines. Diseases emerge more frequently and spread quickly in the aquaculture sector. The general administration and suitability of facilities are the most important factors to expand aquatic animal healthcare.

The ideal immunisation should guard against a wide range of diseases and aid in the avoidance of any illness while also being safe for the fish, the persons immunising the fish, and the end-user. Additionally, it offers continuous protection all through the life cycle. Aquaculture vaccines are made in a way that makes them easy to administer and allows for simultaneous administration to numerous fish species. These vaccinations must meet several important criteria, including being accessible and FDA-licensed and registered.

The vaccination of farmed fish offers significant advantages in the battle against bacterial and viral illnesses without the unfavourable side effects of drugs. Antibiotic use also breeds antibiotic resistance, which reduces aquaculture productivity and causes significant financial losses.

Request Customization @  https://www.futuremarketinsights.com/customization-available/rep-gb-16501

In certain European countries, like Norway, antibiotics are no longer used in aquaculture operations. This has reduced the possibility of antibiotic resistance and positively impacted the market for aquaculture immunisations. With the introduction of DNA and subunit vaccines, aquaculture vaccinations would also become more popular than antibiotics as a result of scientific advancements.

In North America, the aquaculture vaccines market is anticipated to expand at a CAGR of 8%. Important companies like Merck & Co. and Zoetis Inc. are expanding their R&D expenditures, which is improving regional industry revenue. Government funding for the creation of aquaculture vaccines will also increase market share.

Europe will remain one of the most attractive markets for commercial aquaculture vaccinations over the anticipated time frame. For instance, Norway is a major exporter of salmon due to its supportive public and commercial sector initiatives, growing public concern over antimicrobial resistance, and the presence of important actors.

Market Segments Covered in Aquaculture Vaccines Industry Analysis

Product Type Outlook:

Attenuated Live Vaccines

Inactivated Vaccines

Subunit Vaccines

DNA Vaccines

Recombinant Vaccines

Route of Administration:

Oral

Injected

Immersion & Spray

Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16501

Regional Outlook:

Bacterial

Viral

Parasitic

[imr-riya]

Protein Hydrolysate For Animal Feed Application Market - Growth, Trends, Covid-19 Impact, and Forecast (2022 - 2028)

Protein Hydrolysate for Animal Feed Application Market was valued at USD 542.50 million in 2021 and is expected to reach USD 960.30 million by the year 2028, at a CAGR of 8.5 %.

Protein hydrolysate is the product that is obtained by the breakdown of protein. Protein hydrolysate is a collective term called for long peptides, short peptides, and amino acids. Moreover, protein hydrolysate has shown remarkable effects in boosting the immune system and aiding in the digestion process of various animals. Furthermore, peptides present in hydrolysate have demonstrated qualities like antioxidant, anticoagulation, anti-microbial, anticancer, and antihypertension. The antimicrobial quality of protein hydrolysate prevents the growth of harmful bacteria in the gut of animals thus promoting the growth of helpful bacteria and an increase in feed uptake. The large and small peptides generated by hydrolysis of protein hydrolysate have shown both nutritional and physiological or regulatory functions in livestock, fish, and poultry thus, supporting the expansion of the market during the forecast period. The high quality of protein content in protein hydrolysate is associated with the proper growth and development of animal cells and also helps in boosting immunity. In addition, protein hydrolysate is organic and is environmentally friendly. Furthermore, with the growing awareness towards animal health and nutrition as well as to cut down the use of expensive antibiotics, livestock holders are switching to the use of organic and animal-friendly protein hydrolysate. Solubility of protein hydrolysate in a wide range of pH is an ideal characteristic that helps in improvised water holding, foaming, oil binding, and emulsifying properties.

The Protein Hydrolysate For Animal Feed Application Market analysis summary is a comprehensive examination of the present developments in many areas that are driving this vertical trend. Market share, applications, market size, statistics, and sales are all summarized in this report. Furthermore, this research highlights a detailed competition analysis of market possibilities, particularly growth plans as claimed by industry specialists. The Protein Hydrolysate For Animal Feed Application market report examines the competitive environment in terms of markets, applications, and regions to assist the vendor in determining a match or alignment between their strengths and future growth potential.

To learn more about this report, request a free sample copy:

https://introspectivemarketresearch.com/request/16036

Key Industry Players in Protein Hydrolysate For Animal Feed Application Market:

·         Copalis Sea Solutions (France)

·         GELITA AG (Germany)

·         Janatha Fish Meal & Oil Products (India)

·         Shenzhen Taier (China)

·         Hofseth BioCare ASA (Norway)

·         Bio-marine Ingredients Ireland (Ireland)

·         Scanbio Marine Group AS (Norway)

·         SOPROPÊCHE (France)

·         TripleNine (Denmark)

·         Aller Aqua (Denmark)

·         CRESCENT BIOTECH (India)

·         Kemin Industries Inc (US)

·         Azelis (Belgium) and other major players.

The protein hydrolysates for animal feed application market is segmented on the basis of source, form, livestock, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Segmentation Analysis Includes,

By Technology:

·         Enzymatic Hydrolysis

·         Autolysis

·         Microbial Hydrolysis

·         Chemical Hydrolysis

By Livestock:

·         Poultry

·         Cattle

·         Aquatic

·         Swine

·         Other

By Form:

·         Powder

·         Granules

·         Paste

·         Liquid

By Sources:

·         Fish Source

·         Plant Source

·         Milk Source

·         Animal Source

By Region:

·         North America (U.S., Canada, Mexico)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

·         Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

·         South America (Brazil, Argentina, Rest of SA)

 Will you have any doubt about this report? Please contact us on:   

https://introspectivemarketresearch.com/inquiry/16036

Reasons to purchase this report:

·         This ultimate guide will help you stay ahead in market as it furnishes you with the profiles of the key market players and their working methodologies and their decision-making capabilities.

·         The report analyzes various factors which act as drivers and restraints to development the overall Microplate Reader market.

·         This report not only analyzes present market condition but it likewise estimates how the Microplate Reader market is going to perform for estimated time period of 2028.

·         It enables you to adopt smart methodologies and form better decisions by giving a clear idea about customer’s requirement and preferences regarding the product in particular region.

Protein hydrolysates are processed food ingredient that is obtained by breaking down the proteins into smaller units called peptides and amino acids. These peptides and amino acids are easier to digest and are absorbed quickly by the body. This makes protein hydrolysates an ideal ingredient for use in infant formula, sports nutrition products, weight management supplements, and other medical foods.

Purchase This Report: -

https://introspectivemarketresearch.com/checkout/?user=1&_sid=16036

The protein hydrolysate market for animal feed has been segmented on the basis of technology, form, source, livestock, and region. Based on source, the market has further been segmented into fish protein hydrolysates, animal protein hydrolysates (bovine, poultry, pig, and other meat), plant protein hydrolysates (sunflower protein, soy protein, and others), and milk protein hydrolysates (casein and whey).

Related Report: -

https://introspectivemarketresearch.com/reports/fish-protein-hydrolysate-market/

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

Linkedin| Twitter| Facebook

Email: sales@introspectivemarketresearch.com

[rohit890]

veterinary antimicrobial susceptibility testing Market Summary Comprises Key Regions, Growth And Segmentation Till 2031

Market Overview

The global veterinary antimicrobial susceptibility testing market was valued at USD 28.6 billion in 2021 and it is anticipated to grow up to USD 59.4 billion by 2031, at a CAGR of 7.6% during the forecast period.

Veterinary antimicrobial susceptibility testing are simple and easy to perform. These tests are more accurate than others and can be performed at home. Veterinary rapid tests produce immediate results, allowing for immediate treatment. These tests do not require any expensive equipment, and people can learn how to perform them on their pets in a matter of hours. Veterinary antimicrobial susceptibility testing are used to conduct experiments that can control a factor that affects an animal’s biological system or behavior. Its goal is to find a specific treatment for any disease.

View Detailed Report Description: https://www.globalinsightservices.com/reports/veterinary-antimicrobial-susceptibility-testing-market/

Market Dynamics

Global livestock population is rapidly increasing. Demand for livestock products is increasing in both developing and developed countries. This has raised concerns about livestock health. According to the United States Department of Agriculture’s National Agricultural Statistics Service, the number of cattle and calves in the United States in January 2021 was 93,594,500, and the number of beef cows was 31,157,600. Because of rising urbanization, consumers are becoming more aware of the nutritional value of animal protein. There is also a growing demand for healthy, sustainable, and high-quality meat products, particularly those with few or no antibiotics. This, in turn, raises the demand for antimicrobial susceptibility testing (AST).

One of the most significant disadvantages of traditional or manual veterinary antimicrobial susceptibility testing methods (such as agar dilution, chromogenic agar method, disc diffusion, and micro-broth dilution) is the time required to obtain results, which can range from 24 to 48 hours. Automated veterinary antimicrobial susceptibility testing systems deliver results faster, with greater accuracy, and with fewer chances of human error. However, due to their high cost, adoption of these systems in veterinary laboratories is limited, mainly in developing countries.

Get Free Sample Copy of This Report: https://www.globalinsightservices.com/request-sample/GIS10376

The key players in the market are BioMérieux SA (France), Thermo Fisher Scientific (US), Bruker Corporation (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Synbiosis (UK), Liofilchem S.r.l. (Italy), HiMedia Laboratories (India), Bio-Rad Laboratories (US), Neogen Corporation (US), among others.

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1–833–761–1700

[petnews2day]

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type, By Drug Class, By Dosage Form And Segment Forecasts, 2022

New Post has been published on https://petnews2day.com/pet-industry-news/pet-insurance-news/europe-veterinary-antibiotics-market-size-share-trends-analysis-report-by-animal-type-by-drug-class-by-dosage-form-and-segment-forecasts-2022/

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type, By Drug Class, By Dosage Form And Segment Forecasts, 2022

ReportLinker

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Poultry), By Drug Class (Macrolides, Penicillins), By Dosage Form (Oral Solution, Oral Powder), And Segment Forecasts, 2022 – 2030

New York, Nov. 08, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type, By Drug Class, By Dosage Form And Segment Forecasts, 2022 – 2030” – https://www.reportlinker.com/p06360885/?utm_source=GNW

Europe Veterinary Antibiotics Market Growth & Trends

The Europe veterinary antibiotics market size is expected to reach USD 1.31 billion by 2030, registering a CAGR of 3.59% over the forecast period. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry’s growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry’s growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities.However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements.

Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020.Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health.

Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge.For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies.

These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

Europe Veterinary Antibiotics Market Report Highlights • The cattle animal type segment accounted for the largest revenue share in 2021 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products • By drug class, the penicillin segment held the largest revenue share in 2021. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application • According to the EMA, the overall sales of veterinary penicillin accounted for 31.1% in 2020 • The oral solution segment led the market in 2021 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water • The U.K. accounted for the largest revenue share in 2021 and Poland is expected to grow at the fastest CAGR from 2022 to 2030 • Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates • The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry Read the full report: https://www.reportlinker.com/p06360885/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Story continues

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

[marketing123456789]

Eubiotics Market Size, Share, Trend Research Profiling Players to Witness Massive Growth by 2031

As per Future Market Insights (FMI) analysis, the global consumption of eubiotics increased by year-on-year (YoY) rate of 6.7% in 2021 to total sales of US$ 2.68 Bn in the year. The overall demand for eubiotics represents 16.4% of the global animal feed market in 2021 and is poised to increase at 7.4% CAGR to reach a value of US$ 5.47 Bn in 2031.

The eubiotics market is emerging as antibiotic alternatives or animal antimicrobials by-product in the animal feed industry intended to boost livestock immunity and gut health while acting as livestock nutrition.  Considering this, the increasing demand for animal feed additives and animal specialty drugs will result in high demand for eubiotics market.

The demand for eubiotics is growing as animal farming industries aim for improved effeciency, which includes an increase in livestock yield. Antibiotics, for the longest time, have remained crucial for improving animal productivity. Antibiotics are still in use in many countries as a sub-therapeutic substance for animal growth. But banning of antibiotics is encouraging manufacturers to go for alternative solutions, controlling the rise of AMR (anti-microbial resistance) products at the global level.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11087

Eubiotics, such as prebiotics, probiotics, enzymes, and organic acids, can add the essential nutritional components to reduce the antibiotic use in farmed animals that can enable the industry to grow further. Key manufacturers like DSM are developing effective eubiotics solutions to reduce the prophylactic use of antibiotics and to remove AGPs to tackle AMR, to switch to antibiotic-free animal diets smoothly over time.

 Key Takeaways from the Eubiotics Market Study:

North America eubiotics market leads accounted for 31.1% of the global eubiotics market in 2021.

Based on type, organic acid accounted for a dominant market share of 48.3% in the global market in 2021.

In terms of form, the liquid form is anticipated to register a CAGR of 7.8% during the forecast period (2021-2031).

By function, nutrition and gut health segment is accounted for 37.9% of the total market share in 2021.

Among livestock segments, demand for eubiotics in aquaculture is anticipated to increase by a CAGR of 8.1% during the forecast period.

Who is winning?

Mature eubiotics markets can be influenced by consumer behavioral changes to dictate the demand-supply balance paradigm and the critical demographic position of the market as well. Focus on environmental sustainability is the broad level indicator of growth of the eubiotics market, as governments and regulatory bodies are introducing stringent rules regarding standard eubiotics products.

According to the Veterinary Medicines Regulation, published on December 11, 2018, the regulatory body has identified the need to control use of antimicrobial farm animal products and has put a ban on the prophylactic and metaphylactic antimicrobials usage in animals. The regulation will come into effect from January 28, 2022, compelling manufacturers to convert the antibiotic based products into sustainable alternatives like eubiotics.

Some of the leading companies offering eubiotics are Cargill Inc., BASF SE, Koninklijke DSM N.V., Novozymes, Eubiotics, Lesaffre Group, Kemin Industries, Inc., Novus International, Inc., Chr. Hansen Holding A/S, Beneo Group, and others.

Eubiotics by Category

By Type, eubiotics is segmented as:

Probiotics

Prebiotics

Organic Acid

Essential Oil

Enzymes

By Form, eubiotics is segmented as:

Dry

Liquid

By Function, eubiotics is segmented as:

Nutrition and Gut Health

Yield

Immunity

By Livestock, eubiotics is segmented as:

Cattle

Poultry

Swine

Aquaculture

Others

By Region, eubiotics is segmented as:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

Preview Full Report@ https://www.futuremarketinsights.com/reports/eubiotics-market

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

[naturesnectar1]

More About Acacia Honey

Bees in North America and Europe make acacia honey by pollinating the black locust tree. Probably attributable to its high antioxidant content, it is reported to provide a number of health advantages. Honey from the Robinia pseudoacacia tree, sometimes called the black locust or false acacia tree, is the source of true acacia honey. In the Natures nectar people can find that they are having the best honey.

In Europe, this special honey is known as raw acacia honey, but in the United States you can see it labelled as American acacia honey or locust honey. It typically has a considerably paler hue than regular honey, sometimes almost looking translucent. It smells and tastes like flowers—sweet and light. In a practical twist, acacia honey takes significantly longer to crystallize than regular honey and stays liquid for a longer period of time. One possible explanation is that it contains more of the sugar fructose. This honey might be more costly than regular honey since it lasts longer without hardening.

Analysis of Acacia Honey's nutritional value

One tablespoon (or 21 grammes) of acacia honey, like regular honey, has around 60 calories and 17 grammes of sugar. Fructose is the most abundant of the three sugars found in acacia honey (glucose and sucrose are also present). It has no beneficial nutrients like as protein, fat, or fibre. However, it does include trace levels of nutrients including vitamin C and magnesium. Beneficial plant elements like flavonoids, found in abundance in acacia honey, have antioxidant properties. Raw pure acacia honey honey contains mostly sugars and is a potent source of plant chemicals with antioxidant qualities.

Acacia honey and its many uses

As delicious as acacia honey is, its applications extend well beyond the kitchen. It contains many of the same beneficial characteristics as regular honey, but also has some of its own.

Full with healthy antioxidants

The high levels of antioxidants found in acacia honey suggest it could have some positive health effects. Antioxidants prevent free radicals from harming your cells. Long-term free-radical damage may have a role in the development of illness. In particular, flavonoids are what give acacia honey its antioxidant properties. Several chronic diseases, including cardiovascular disease and several forms of cancer, may be avoided with a diet rich in flavonoids. The jamun honey is having a great taste in itself.

Beta carotene, a kind of plant pigment with high antioxidant qualities, is present in this honey, but at a much lower concentration than flavonoids. Better cognitive performance and skin health have both been linked to a diet high in beta-carotene. Honey from the acacia tree has been shown to inhibit the growth of lung cancer cells in vitro. For the raw jamun honey you can search in the online market.

Having antimicrobial effects in nature

Antibacterial properties of acacia honey are likely responsible for many of the beneficial effects of this honey. Honey has enzymes and other components that are used to make hydrogen peroxide, which are then released gradually. Researchers found that acacia honey inhibited the growth of antibiotic-resistant bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. It found that the high concentrations of hydrogen peroxide in the substance were to blame. For getting organic jamun honey then enjoy with it.

Can potentially help with wound recovery

Since ancient times, honey has been utilised as a remedy for wounds. Acacia honey's antibacterial and antioxidant characteristics may aid in the healing of wounds and keep them free from infection. This honey not only provides a protective barrier but also helps keep the wound moist, both of which are important for speedy recovery. Animal and in vitro research show that acacia honey hastens wound recovery, proving the effectiveness of this traditional remedy.

[vinayakshinde]

Latin America Animal Feed Additives Market by Competitive Strategies, Trends Analysis and Forecast to 2027

Latin America Animal Feed Additives Market size is projected to surpass USD 3.5 billion by 2027. Rising demand for supplements in livestock and increasing consumption for meat & meat products are some of the important reasons which are creating various opportunities for the animal feed additives market.

The acidifiers market size should surpass USD 375 million by 2020. Acidifiers will witness substantial demand owing to its ability to improve the immune response in animals by favorably manipulating the intestinal microbial populations. They perform an activity like antibiotics in animals and counters pathogenic bacteria which will fuel acidifiers demand for animal feed application thus fostering market growth. 

Request for a sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5183

Some major findings of the Latin America animal feed additives market report include:

The probiotics animal feed additives market should grow at a CAGR of over 5.5%. The impact of probiotics on intestinal bacteria is of prime importance owing to which it is widely used in animal feed thus fueling product demand. 

The pigments product surpassed USD 150 million in 2020, mainly due to rising awareness about the health benefits of carotenoids in animals and increasing preference for pellet feed are anticipated to escalate the use of pigments in animal feed.

Aquaculture livestock are likely to surpass USD 110 million by 2027 owing to increasing preference of consumers for low calorie healthy diet.

Argentina product demand is mainly driven by increasing livestock safety concern coupled with enhancing the meat quality which in turn should boost the market growth

The market is competitive and includes manufacturers such as ADM, DSM, BASF SE, Alltech Inc., Evonik Industries AG, Kemin Industries, Cargill Incorporated, and Dupont

Acidifiers such as propionic acid finds extensive adoption as feed additive in poultry feed owing to its ability to improve the overall performance of poultry which will promote product demand. Propionic acid with effective health enhancing, growth promoting, as well as antimicrobial effects is considered as an alternative to antibiotic growth promoters in poultry production.

The Latin America animal feed additives market size from swine livestock should surpass USD 800 million by 2027. Swine requires additives in every stage of their life cycle to ensure a normal growth and body function. The diet of swine needs to be healthy and balanced with desirable levels and ratio of various additives which provides a balanced feed. Rising penetration of technologies to reduce environmental footprint and increasing focus of livestock breeders to increase their return on investment should strengthen product demand. 

Argentina animal feed additives market is likely to register over 5.5% CAGR and market size should surpass USD 370 million by 2027 on account of increasing beef exports. Argentina has witnessed significant growth in beef exports in recent years which has strengthened the country’s market position as a beef supplier. 

Browse report summary @ https://www.gminsights.com/industry-analysis/latin-america-animal-feed-additives-market

Argentina has boosted its beef exports to China in recent years which has also helped the country to contribute significantly to its economy. Thus, increasing global demand for beef has influenced Argentina to increase its domestic production which should stimulate the demand for animal feed additives in the country.

Latin America animal feed additives market share is competitive and comprises various companies such ADM, DSM, BASF SE, Alltech Inc., Evonik Industries AG, Kemin Industries, Cargill Incorporated, and Dupont. The animal feed additives market competitiveness is projected to surge over the foreseeable timeframe as the leading manufacturers are focusing on various strategies to gain a competitive edge and improve their profit margins.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com/